Nephrin expression is reduced in human diabetic nephropathy: evidence for a distinct role for glycated albumin and angiotensin II.
about
Epithelial-to-Mesenchymal Transition in Diabetic Nephropathy: Fact or Fiction?Molecular mechanisms of diabetic kidney diseaseDiabetes Induced Changes in Podocyte Morphology and Gene Expression Evaluated Using GFP Transgenic Podocytes.Endothelin-1 increases glomerular permeability and inflammation independent of blood pressure in the ratDysregulated nephrin in diabetic nephropathy of type 2 diabetes: a cross sectional studyClinical therapeutic strategies for early stage of diabetic kidney disease.beta-Arrestin2 mediates nephrin endocytosis and impairs slit diaphragm integrity.Nephrin is expressed on the surface of insulin vesicles and facilitates glucose-stimulated insulin release.Podocytic PKC-alpha is regulated in murine and human diabetes and mediates nephrin endocytosis.A molecular profile of focal segmental glomerulosclerosis from formalin-fixed, paraffin-embedded tissue.Comparative effect of direct renin inhibition and AT1R blockade on glomerular filtration barrier injury in the transgenic Ren2 ratCannabinoid receptor 1 blockade ameliorates albuminuria in experimental diabetic nephropathy.Angiotensin receptor blocker protection against podocyte-induced sclerosis is podocyte angiotensin II type 1 receptor-independent.Claudin 1 and nephrin label cellular crescents in diabetic glomerulosclerosisChronic endothelin-1 infusion elevates glomerular sieving coefficient and proximal tubular albumin reuptake in the ratTrophoblast glycoprotein: possible candidate mediating podocyte injuries in glomerulonephritisNPHS2 (Podocin) mutations in nephrotic syndrome. Clinical spectrum and fine mechanisms.Role of endothelial nitric oxide synthase in diabetic nephropathy: lessons from diabetic eNOS knockout miceOverexpression of Mafb in podocytes protects against diabetic nephropathy.Glomerular handling of native albumin in the presence of circulating modified albumins by the normal rat kidney.Recent advancement of understanding pathogenesis of type 1 diabetes and potential relevance to diabetic nephropathy.Nontraditional markers of glycemia: associations with microvascular conditions.Decreased nephrin and GLEPP-1, but increased VEGF, Flt-1, and nitrotyrosine, expressions in kidney tissue sections from women with preeclampsiaInhibition of mineralocorticoid receptor is a renoprotective effect of the 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor pitavastatin.Amadori albumin in diabetic nephropathyMessenger RNA levels of podocyte-associated proteins in subjects with different degrees of glucose tolerance with or without nephropathyManifestation of renal disease in obesity: pathophysiology of obesity-related dysfunction of the kidneyRelevance of VEGF and nephrin expression in glomerular diseases.Knockout of toll-like receptor-2 attenuates both the proinflammatory state of diabetes and incipient diabetic nephropathyProtective role of cannabinoid receptor type 2 in a mouse model of diabetic nephropathy.Transcriptome analysis of human diabetic kidney diseaseProximal tubule dysfunction is associated with podocyte damage biomarkers nephrin and vascular endothelial growth factor in type 2 diabetes mellitus patients: a cross-sectional study.Early-onset diabetic E1-DN mice develop albuminuria and glomerular injury typical of diabetic nephropathy.Early treatment with olmesartan prevents juxtamedullary glomerular podocyte injury and the onset of microalbuminuria in type 2 diabetic rats.Conformational transitions and glycation of serum albumin in patients with minimal-change glomerulopathy.Diet-Induced Podocyte Dysfunction in Drosophila and Mammals.Protective effects of leukemia inhibitory factor against oxidative stress during high glucose-induced apoptosis in podocytes.Effect of Tongxinluo on Nephrin Expression via Inhibition of Notch1/Snail Pathway in Diabetic RatsNephrin Preserves Podocyte Viability and Glomerular Structure and Function in Adult Kidneys.ARB protects podocytes from HIV-1 nephropathy independently of podocyte AT1.
P2860
Q26782283-8F9F3F79-DC53-434C-9E7A-C594D6D8D076Q27003963-551FC81E-AA40-4B07-9632-29F6551A855EQ27301030-E089E4E5-3607-43FF-88C4-1598F9718DF8Q28575856-73186810-646B-42BF-BA84-8376ECAF3A80Q28729900-4BD9B9E5-FC33-4EA9-92F9-84052AA77438Q30363683-CBD30F7E-EA20-4A87-A89F-87A1045D743EQ30477945-E84AFFA1-568C-42B6-A800-594D380035DEQ33556517-C140F359-C5C4-4FBC-8D38-566E70BE3E81Q33564333-0E4E6923-EB3C-40B3-9BE8-E18D488BD3C9Q33694240-3D3D9F40-3DE0-4FB5-B729-3C68B63CC8CAQ33727755-CFC150AE-433C-45C8-9316-1FA56281EF02Q33750632-05B132EB-E125-4534-B91A-83ABE6AD80E5Q33920991-F5F1010B-2EB1-4767-AE2E-0E6D7E13C9CCQ34142092-6A2CD49C-4CD9-4F68-9C5F-D62727751D7AQ34315591-FF0E6664-A95E-46CE-BFD0-240A9E537DABQ34354544-2F5BEF93-54DD-4206-BC63-D5B513F9A1F4Q34409698-0B300EAD-B50D-4A1D-8863-506C97D9B13BQ34412951-10882EE3-EBD0-4DC7-A772-FE6E3876567CQ34427651-500092CA-7497-4971-8234-EB7C5DCA4461Q34433576-E0300FF8-9454-414B-8DB6-39C6FF1DB8B9Q34682220-B2190B04-60E8-4381-88FE-870D0264C3F1Q34718472-79AB1160-FA88-4946-A715-60479132BBC3Q34731351-79279B84-23F9-46F6-A788-C3462C435138Q34759691-89A47858-8A07-458F-80AD-27727DAAE1C9Q34878346-4AD25B1D-98B5-4F43-9084-9905C424A312Q35011234-0EAE7191-E56F-40C3-AFC2-FE05B4F77945Q35026645-AFA1AD26-A5F2-47D5-9D89-764BBE8F85C8Q35131059-2E992676-46AB-49A5-8A34-E81EF42844E0Q35143026-E20ECDC6-390B-4289-A400-704F00BA16C2Q35179985-A6D1E1E5-3831-4495-9E9B-875ADE0308C7Q35180096-7E5C7C53-1D38-40A7-BFD4-0942DE14092CQ35421414-948BE530-ADB1-4619-BA05-8C0A9F845AF2Q35591301-16021ED0-25D6-4D1F-B415-AAA150D9CB56Q35894709-8CCAA7D7-0537-43A9-A736-8E8284C1967FQ35936882-E34A5FFA-451D-4F51-A2CC-3A397B5E5F33Q35941157-DE9A72E9-D599-4A34-AD86-C93B546DD5F9Q36010534-FACEE511-3040-4ECD-A2BB-7DEEA93222FEQ36055970-0C025095-C5B2-4FCE-A464-AC6225CC364EQ36104788-2889D97D-C17B-49E5-8964-D093163B8E69Q36129864-0FD3F9F9-2751-4CB3-A81D-9C2E2CA031E7
P2860
Nephrin expression is reduced in human diabetic nephropathy: evidence for a distinct role for glycated albumin and angiotensin II.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Nephrin expression is reduced ...... ed albumin and angiotensin II.
@en
Nephrin expression is reduced ...... ed albumin and angiotensin II.
@nl
type
label
Nephrin expression is reduced ...... ed albumin and angiotensin II.
@en
Nephrin expression is reduced ...... ed albumin and angiotensin II.
@nl
prefLabel
Nephrin expression is reduced ...... ed albumin and angiotensin II.
@en
Nephrin expression is reduced ...... ed albumin and angiotensin II.
@nl
P2093
P1433
P1476
Nephrin expression is reduced ...... ed albumin and angiotensin II.
@en
P2093
Daniela Verzola
Enrico Lupia
Gennaro Salvidio
Giacomo Deferrari
Giovanni Camussi
Sophie Doublier
Vesa Ruotsalainen
P304
P356
10.2337/DIABETES.52.4.1023
P407
P577
2003-04-01T00:00:00Z